Clinical Trials Directory

Trials / Completed

CompletedNCT01025518

DAHANCA 25A: Resistance Training and Dietary Supplements as Intervention for Regaining Muscle Mass Following Radiotherapy in Head and Neck Cancer Patients

A Randomized Trial Evaluating Resistance Training and Dietary Supplements as Intervention for Regaining Muscle Mass Following Radiotherapy in Head and Neck Cancer Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Danish Head and Neck Cancer Group · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate whether resistance training in combination with dietary supplementation is tolerable among head and neck cancer patients and to evaluate the possible effect on muscle mass, strength and functional capacity.

Detailed description

Head and neck cancer patients experience a significant loss of muscle mass following radiotherapy treatment due to cachexia and dysphagia. This negatively affects muscle strength and functional capacity. Studies on healthy individuals and various groups of patients show that resistance training in combination with protein and creatine ingestion is an effective means of increasing muscle mass, strength and functional capacity. Thus the aim is to investigate the following: * is resistance training and dietary supplements tolerable among head and neck cancer patients * the effect of the intervention on muscle mass, strength and functional capacity

Conditions

Interventions

TypeNameDescription
OTHERResistance training12 weeks of resistance training in combination with protein and creatine or placebo ingestion
DIETARY_SUPPLEMENTProtein and creatine30 g of protein with each training session, 5 g of creatine pr day
DIETARY_SUPPLEMENTPlaceboMaltodextrine

Timeline

Start date
2009-09-01
Primary completion
2012-01-01
Completion
2012-01-01
First posted
2009-12-03
Last updated
2016-11-29

Locations

2 sites across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01025518. Inclusion in this directory is not an endorsement.